Showing 1 - 8 results of 8 for search '"IL-17 inhibitor"', query time: 0.37s Refine Results
  1. 1
    Paradoxical Behçet’s Disease after Ixekizumab: A Case Report and Literature Review

    Paradoxical Behçet’s Disease after Ixekizumab: A Case Report and Literature Review by Yue-Kang Ren, Ling Ren, Wen Sun, Hong-Ye Liu, Shu-Ping Guo

    Published 2025-01-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    IL-17-neutralizing antibody mitigates functional and structural changes in cigarette smoke-induced COPD model

    IL-17-neutralizing antibody mitigates functional and structural changes in cigarette smoke-induced COPD model by Alyne Riani Moreira, Camila Uchoa da Silva, Leticia de Paula Costa Mattos, Jussara Jesus Simão, Veronica Camargo Berti, Luan Henrique Vasconcelos Alves, Alex Ferreira da Silva, Franciele Jesus Lima, Suellen Karoline Moreira Bezerra, Cintia Nascimento Silva, Maria Isabel Cardoso Allonso- Vale, Iolanda de Fatima Lopes Calvo Tiberio, Francine Maria Almeida, Fernanda Degobbi Tenorio Quirino dos Santos Lopes, Fernanda Degobbi Tenorio Quirino dos Santos Lopes

    Published 2025-08-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Risk of new-onset and recurrent uveitis with different biologics for ankylosing spondylitis: a network meta-analysis

    Risk of new-onset and recurrent uveitis with different biologics for ankylosing spondylitis: a network meta-analysis by Xu Zhao, Xu Zhao, Xu Zhao, Qingqing Xie, Qingqing Xie, Xinyi He, Xinyi He, Xinyi He, Yiwei Lu, Yiwei Lu, Yiwei Lu, Menglan Li, Menglan Li, Menglan Li, Shiquan Shuai, Shiquan Shuai, Shiquan Shuai

    Published 2025-06-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Acrodermatitis continua of Hallopeau: a review and update on biological and small molecule targeted immunomodulatory therapies

    Acrodermatitis continua of Hallopeau: a review and update on biological and small molecule targeted immunomodulatory therapies by Qiong Sun, Luyao Han, Zhimin Lin, Yuanhao Wu, Chen Li, Zhenhua Ying, Zhenhua Ying, Zhenhua Ying, Zuotao Zhao

    Published 2025-08-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Real-world experience with brodalumab in a Portuguese cohort of patients with moderate-to-severe psoriasis

    Real-world experience with brodalumab in a Portuguese cohort of patients with moderate-to-severe psoriasis by Tiago Torres, Pedro Mendes-Bastos, Joana Antunes, Maria João Cruz, Fernando Mota, Paulo Ferreira

    Published 2025-03-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Nonscrapable yeast: A case of chronic hyperplastic candidiasis following secukinumab therapy

    Nonscrapable yeast: A case of chronic hyperplastic candidiasis following secukinumab therapy by Gabriela A. Duchesne, BS, Renee M. Copeland, MD, Rafik A. Abdelsayed, DDS, BDS, MS, Loretta S. Davis, MD

    Published 2025-09-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Behcet’s-like disease induced by secukinumab in a patient with psoriasis: a case report and literature review

    Behcet’s-like disease induced by secukinumab in a patient with psoriasis: a case report and literature review by Kecen Liu, Jingru Sun

    Published 2024-12-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience

    Retention rate of TNF inhibitors versus IL-17 inhibitors in ankylosing spondylitis patients with prior biologics experience by Jiwon Yang, Bong-Woo Lee, Youngjae Park, Ji Hyeon Ju, Wan-Uk Kim, Sung-Hwan Park, Seung-Ki Kwok, Jennifer Jooha Lee

    Published 2025-07-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: